关注
yunhai li
yunhai li
the first affiliated hospital of chongqing medical university
在 hospital.cqmu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinicopathological characteristics and breast cancer–specific survival of patients with single hormone receptor–positive breast cancer
Y Li, D Yang, X Yin, X Zhang, J Huang, Y Wu, M Wang, Z Yi, H Li, H Li, ...
JAMA network open 3 (1), e1918160-e1918160, 2020
1302020
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Y Li, J Huang, B Zeng, D Yang, J Sun, X Yin, M Lu, Z Qiu, W Peng, ...
Cancer letters 430, 109-122, 2018
952018
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
Y Li, J Huang, D Yang, S Xiang, J Sun, H Li, G Ren
Oncology letters 15 (6), 9216-9230, 2018
692018
Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
L Gan, Z Qiu, J Huang, Y Li, H Huang, T Xiang, J Wan, T Hui, Y Lin, H Li, ...
International Journal of Biological Sciences 12 (12), 1533, 2016
622016
Prevalence of thyroid nodules in China: a health examination cohort-based study
Y Li, C Jin, J Li, M Tong, M Wang, J Huang, Y Ning, G Ren
Frontiers in Endocrinology 12, 676144, 2021
452021
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers
Y Li, J Huang, J Sun, S Xiang, D Yang, X Ying, M Lu, H Li, G Ren
Oncotarget 8 (3), 4501, 2017
402017
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer
B Zeng, Y Li, Y Feng, M Lu, H Yuan, Z Yi, Y Wu, T Xiang, H Li, G Ren
Biochemical and biophysical research communications 505 (1), 302-308, 2018
372018
CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis
M Lu, Y Wu, B Zeng, J Sun, Y Li, J Luo, L Wang, Z Yi, H Li, G Ren
Biochemical and Biophysical Research Communications 526 (2), 306-313, 2020
342020
Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
Y Li, D Yang, P Chen, X Yin, J Sun, H Li, G Ren
Aging (Albany NY) 11 (16), 6286, 2019
292019
Downregulated CDKN1C/p57kip2 drives tumorigenesis and associates with poor overall survival in breast cancer
Z Qiu, Y Li, B Zeng, X Guan, H Li
Biochemical and biophysical research communications 497 (1), 187-193, 2018
262018
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
Y Wu, Z Yi, J Li, Y Wei, R Feng, J Liu, J Huang, Y Chen, X Wang, J Sun, ...
Theranostics 12 (10), 4564, 2022
242022
Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease
Y Li, P Chen, J Sun, J Huang, H Tie, L Li, H Li, G Ren
Scientific reports 6 (1), 33550, 2016
62016
Prognostic significance of CCL20 and its receptor CCR6 in cancers: a meta-analysis
Y Li, J Huang, H Tie, H Huang, H Li, G Ren
Int. J. Clin. Exp. Med 9, 1908-1919, 2016
52016
系统目前无法执行此操作,请稍后再试。
文章 1–13